- Home
- BANR vs DYN Comparison
BANR vs DYN Comparison
Compare BANR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- DYN
- Stock Information
- Founded
- BANR 1890
- DYN 1984
- Country
- BANR United States
- DYN United States
- Employees
- BANR N/A
- DYN N/A
- Industry
- BANR Major Banks
- DYN Medicinal Chemicals and Botanical Products
- Sector
- BANR Finance
- DYN Health Care
- Exchange
- BANR Nasdaq
- DYN Nasdaq
- Market Cap
- BANR 2.3B
- DYN 2.6B
- IPO Year
- BANR 1995
- DYN 2020
- Fundamental
- Price
- BANR $63.77
- DYN $10.46
- Analyst Decision
- BANR Buy
- DYN Strong Buy
- Analyst Count
- BANR 6
- DYN 12
- Target Price
- BANR $73.80
- DYN $47.73
- AVG Volume (30 Days)
- BANR 244.9K
- DYN 1.7M
- Earning Date
- BANR 04-16-2025
- DYN 05-01-2025
- Dividend Yield
- BANR 3.01%
- DYN N/A
- EPS Growth
- BANR N/A
- DYN N/A
- EPS
- BANR 4.88
- DYN N/A
- Revenue
- BANR $601,023,000.00
- DYN N/A
- Revenue This Year
- BANR $1.10
- DYN N/A
- Revenue Next Year
- BANR $6.35
- DYN N/A
- P/E Ratio
- BANR $13.07
- DYN N/A
- Revenue Growth
- BANR N/A
- DYN N/A
- 52 Week Low
- BANR $42.00
- DYN $9.96
- 52 Week High
- BANR $78.05
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- BANR 41.88
- DYN 32.32
- Support Level
- BANR $62.87
- DYN $10.72
- Resistance Level
- BANR $66.55
- DYN $12.00
- Average True Range (ATR)
- BANR 1.81
- DYN 0.69
- MACD
- BANR 0.15
- DYN 0.00
- Stochastic Oscillator
- BANR 28.59
- DYN 17.54
Stock Price Comparison Chart: BANR vs DYN
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.